![]() |
||
![]() |
| Tetraphase Pharmaceuticals | ||
Tetraphase Pharmaceuticals is a clinical-stage life science company with a groundbreaking synthetic chemistry technology platform that has the power to deliver solutions to the global health crisis caused by antibiotic resistance. Since the company’s inception in 2006, Tetraphase has developed a robust antibiotic franchise that offers the potential to dramatically improve the treatment of both broad and selective spectrum bacterial infections. |
||
| Pipeline | Partnerships | |
|
|
|
|
January 5, 2012 October 20, 2011 |

Tetraphase's lead candidates have the potential to treat a broad range of serious bacterial infections. This provides a tremendous opportunity to address the global health crisis caused by the increasing number of infections resistant to currently used antibiotics.
The Tetraphase proprietary drug engine has produced more than 2,600 proprietary compounds with novel molecular structures, reinvigorating one of the best known, safest and most efficacious classes of antibiotics ever discovered.
In just five years, Tetraphase has developed a strong pipeline with a lead broad spectrum antibiotic candidate in Phase 2 clinical trials, another drug candidate in Phase 1, and several additional candidates in preclinical development.





